These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 29968805)

  • 1. Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics.
    Nagy-Szakal D; Barupal DK; Lee B; Che X; Williams BL; Kahn EJR; Ukaigwe JE; Bateman L; Klimas NG; Komaroff AL; Levine S; Montoya JG; Peterson DL; Levin B; Hornig M; Fiehn O; Lipkin WI
    Sci Rep; 2018 Jul; 8(1):10056. PubMed ID: 29968805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome.
    Nagy-Szakal D; Williams BL; Mishra N; Che X; Lee B; Bateman L; Klimas NG; Komaroff AL; Levine S; Montoya JG; Peterson DL; Ramanan D; Jain K; Eddy ML; Hornig M; Lipkin WI
    Microbiome; 2017 Apr; 5(1):44. PubMed ID: 28441964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomic Evidence for Peroxisomal Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Che X; Brydges CR; Yu Y; Price A; Joshi S; Roy A; Lee B; Barupal DK; Cheng A; Palmer DM; Levine S; Peterson DL; Vernon SD; Bateman L; Hornig M; Montoya JG; Komaroff AL; Fiehn O; Lipkin WI
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for Peroxisomal Dysfunction and Dysregulation of the CDP-Choline Pathway in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Che X; Brydges CR; Yu Y; Price A; Joshi S; Roy A; Lee B; Barupal DK; Cheng A; Palmer DM; Levine S; Peterson DL; Vernon SD; Bateman L; Hornig M; Montoya JG; Komaroff AL; Fiehn O; Lipkin WI
    medRxiv; 2022 Jan; ():. PubMed ID: 35043127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of metabolomic dysregulation in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis/Systemic Exertion Intolerance Disease (CFS/ME/SEID).
    Huth TK; Eaton-Fitch N; Staines D; Marshall-Gradisnik S
    J Transl Med; 2020 May; 18(1):198. PubMed ID: 32404171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma proteomic profiling suggests an association between antigen driven clonal B cell expansion and ME/CFS.
    Milivojevic M; Che X; Bateman L; Cheng A; Garcia BA; Hornig M; Huber M; Klimas NG; Lee B; Lee H; Levine S; Montoya JG; Peterson DL; Komaroff AL; Lipkin WI
    PLoS One; 2020; 15(7):e0236148. PubMed ID: 32692761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficient butyrate-producing capacity in the gut microbiome is associated with bacterial network disturbances and fatigue symptoms in ME/CFS.
    Guo C; Che X; Briese T; Ranjan A; Allicock O; Yates RA; Cheng A; March D; Hornig M; Komaroff AL; Levine S; Bateman L; Vernon SD; Klimas NG; Montoya JG; Peterson DL; Lipkin WI; Williams BL
    Cell Host Microbe; 2023 Feb; 31(2):288-304.e8. PubMed ID: 36758522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deep phenotyping of myalgic encephalomyelitis/chronic fatigue syndrome in Japanese population.
    Kitami T; Fukuda S; Kato T; Yamaguti K; Nakatomi Y; Yamano E; Kataoka Y; Mizuno K; Tsuboi Y; Kogo Y; Suzuki H; Itoh M; Morioka MS; Kawaji H; Koseki H; Kikuchi J; Hayashizaki Y; Ohno H; Kuratsune H; Watanabe Y
    Sci Rep; 2020 Nov; 10(1):19933. PubMed ID: 33199820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic profiling of a myalgic encephalomyelitis/chronic fatigue syndrome discovery cohort reveals disturbances in fatty acid and lipid metabolism.
    Germain A; Ruppert D; Levine SM; Hanson MR
    Mol Biosyst; 2017 Jan; 13(2):371-379. PubMed ID: 28059425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-'omics of gut microbiome-host interactions in short- and long-term myalgic encephalomyelitis/chronic fatigue syndrome patients.
    Xiong R; Gunter C; Fleming E; Vernon SD; Bateman L; Unutmaz D; Oh J
    Cell Host Microbe; 2023 Feb; 31(2):273-287.e5. PubMed ID: 36758521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential role of microbiome in Chronic Fatigue Syndrome/Myalgic Encephalomyelits (CFS/ME).
    Lupo GFD; Rocchetti G; Lucini L; Lorusso L; Manara E; Bertelli M; Puglisi E; Capelli E
    Sci Rep; 2021 Mar; 11(1):7043. PubMed ID: 33782445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study.
    Lidbury BA; Kita B; Lewis DP; Hayward S; Ludlow H; Hedger MP; de Kretser DM
    J Transl Med; 2017 Mar; 15(1):60. PubMed ID: 28302133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exercise modifies glutamate and other metabolic biomarkers in cerebrospinal fluid from Gulf War Illness and Myalgic encephalomyelitis / Chronic Fatigue Syndrome.
    Baraniuk JN; Kern G; Narayan V; Cheema A
    PLoS One; 2021; 16(1):e0244116. PubMed ID: 33440400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression.
    Maes M; Twisk FN; Ringel K
    Psychother Psychosom; 2012; 81(5):286-95. PubMed ID: 22832503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into Metabolite Diagnostic Biomarkers for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Yamano E; Watanabe Y; Kataoka Y
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33810365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Systematic Review of Probiotic Interventions for Gastrointestinal Symptoms and Irritable Bowel Syndrome in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME).
    Corbitt M; Campagnolo N; Staines D; Marshall-Gradisnik S
    Probiotics Antimicrob Proteins; 2018 Sep; 10(3):466-477. PubMed ID: 29464501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poor sleep quality is associated with greater circulating pro-inflammatory cytokines and severity and frequency of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) symptoms in women.
    Milrad SF; Hall DL; Jutagir DR; Lattie EG; Ironson GH; Wohlgemuth W; Nunez MV; Garcia L; Czaja SJ; Perdomo DM; Fletcher MA; Klimas N; Antoni MH
    J Neuroimmunol; 2017 Feb; 303():43-50. PubMed ID: 28038892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for the existence of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) with and without abdominal discomfort (irritable bowel) syndrome.
    Maes M; Leunis JC; Geffard M; Berk M
    Neuro Endocrinol Lett; 2014; 35(6):445-53. PubMed ID: 25433843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic abnormalities in chronic fatigue syndrome/myalgic encephalomyelitis: a mini-review.
    Tomas C; Newton J
    Biochem Soc Trans; 2018 Jun; 46(3):547-553. PubMed ID: 29666214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new case definition of Neuro-Inflammatory and Oxidative Fatigue (NIOF), a neuroprogressive disorder, formerly known as chronic fatigue syndrome or Myalgic Encephalomyelitis: results of multivariate pattern recognition methods and external validation by neuro-immune biomarkers.
    Maes M
    Neuro Endocrinol Lett; 2015; 36(4):320-9. PubMed ID: 26454487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.